These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1347383)

  • 1. In-vitro activity of zidovudine against Mycoplasma.
    Taylor-Robinson D; Furr PM
    Lancet; 1992 Mar; 339(8794):686-7. PubMed ID: 1347383
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of activity of zidovudine against Ureaplasma urealyticum and Mycoplasma hominis.
    Madoff S; Ferraro MJ; Merrill DP; Hirsch MS
    Lancet; 1992 Aug; 340(8817):484. PubMed ID: 1354810
    [No Abstract]   [Full Text] [Related]  

  • 3. In-vitro activity of zidovudine, zalcitabine, and didanosine against mycoplasmas.
    Ostashewski PM; Houston SC; Robertson JA
    Lancet; 1993 Nov; 342(8881):1242-3. PubMed ID: 7901563
    [No Abstract]   [Full Text] [Related]  

  • 4. In-vitro activity of zidovudine against mycoplasma.
    Papierok G; Lafeuillade A; Dombrecht S; Pautrat G; Pellegrino P; Escarguel C; Quilichini R
    Lancet; 1992 Dec 19-26; 340(8834-8835):1543. PubMed ID: 1361623
    [No Abstract]   [Full Text] [Related]  

  • 5. In-vitro activity of zidovudine against mycoplasma.
    Lafeuillade A; Papierok G; Pautrat G; Escarguel C; Pellegrino P; Quilichini R
    Lancet; 1992 Jan; 339(8785):131. PubMed ID: 1345862
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro activity of various antibiotics against Mycoplasma synoviae.
    Kleven SH; Anderson DP
    Avian Dis; 1971; 15(3):551-7. PubMed ID: 5099154
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro activity of zidovudine alone and in combination with ciprofloxacin against Salmonella and Escherichia coli.
    Mascellino MT; Iona E; Iegri F; De Gregoris P; Farinelli S
    FEMS Immunol Med Microbiol; 1993 Jun; 7(1):23-8. PubMed ID: 8364519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro activities of investigational peptide deformylase inhibitor NVP LBM-415 and other agents against human mycoplasmas and ureaplasmas.
    Waites KB; Reddy NB; Crabb DM; Duffy LB
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2541-2. PubMed ID: 15917568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro antimycoplasmal activity of flurithromycin.
    Furneri PM; Bisignano G; Cerniglia G; Tempera G; Nicoletti G
    J Antimicrob Chemother; 1995 Jan; 35(1):161-5. PubMed ID: 7768764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antimycoplasmal activity of mepartricin.
    Meloni GA; Busolo F; Bortolon P; Ruozi P
    Farmaco Sci; 1979 Mar; 34(3):183-8. PubMed ID: 118890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of gemifloxacin (SB 265805; LB20304a) against human mycoplasmas.
    Hannan PC; Woodnutt G
    J Antimicrob Chemother; 2000 Mar; 45(3):367-9. PubMed ID: 10702559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on the sensitivity of Mycoplasma hyorhinis strains against various antibiotics and against nitrofurazone].
    Buitkamp B; Heitmann J; Kirchhoff H
    Berl Munch Tierarztl Wochenschr; 1978 Jul; 91(13):253-60. PubMed ID: 666718
    [No Abstract]   [Full Text] [Related]  

  • 13. In-vitro activity of ketolides against mycoplasmas.
    Bébéar CM; Renaudin H; Aydin MD; Chantot JF; Bébéar C
    J Antimicrob Chemother; 1997 May; 39(5):669-70. PubMed ID: 9184373
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro activity of chlorhydroxyquinoline against mycoplasma species.
    Cosgrove RF; Baines S
    Antimicrob Agents Chemother; 1978 Mar; 13(3):540-1. PubMed ID: 263891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro sensitivity of New Zealand strains of Mycoplasma ovipneumoniae to some antibiotics.
    Quinlan JR; Alley MR; Clarke JK
    N Z Vet J; 1975 Sep; 23(9):188-9. PubMed ID: 1060971
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro susceptibilities of Mycoplasma hyopneumoniae field isolates.
    Vicca J; Stakenborg T; Maes D; Butaye P; Peeters J; de Kruif A; Haesebrouck F
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4470-2. PubMed ID: 15504886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased in vitro susceptibility to zidovudine of HIV isolates obtained from patients with AIDS.
    Land S; Terloar G; McPhee D; Birch C; Doherty R; Cooper D; Gust I
    J Infect Dis; 1990 Feb; 161(2):326-9. PubMed ID: 2299212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibilities of Mycoplasma putrefaciens field isolates.
    Antunes NT; Tavío MM; Mercier P; Ayling RD; Al-Momani W; Assunção P; Rosales RS; Poveda JB
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3452-4. PubMed ID: 17638695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Design and evaluation of an opacimetric method for determining the in vitro antibiotic sensitivity of Mycoplasma bovis].
    Poumarat F; Martel JL
    Ann Rech Vet; 1989; 20(2):135-43. PubMed ID: 2751227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-mycoplasmal activity of aminosidine.
    Buogo A; Zavaglio V
    Farmaco Sci; 1975 Dec; 30(12):937-46. PubMed ID: 1204831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.